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VIATICAL SETTLEMENT AND ACCELERATED
DEATH BENEFIT LAW: HELPING
TERMINAL, BUT NOT
CHRONICALLY ILL PATIENTS
Alexander D. Eremia"
INTRODUCTION
When serious illness strikes, financial resources are often drained leaving
the sick or their families to deplete their financial resources, scrambling
to sell investments, or digging into retirement funds. Even those with
health insurance often find their coverage insufficient to pay for all
necessary medical expenses.! When coupled with the loss of employment,
serious illness may destroy the dreams or hopes of many individuals and
families. In an effort to ease the financial burdens imposed on the
terminally2 or chronically ill,3 the Health Insurance Portability and
Accountability Act of 1996 (HPAA) was amended.4
*Staff, DEPAULJ. HEALTH CARE L., B.S., Biopsychology, University of California, Santa Barbara,
1991; J.D. (Cand.), DePaul University, 1997.
'See Kathryn Sullivan & Joann Canning, Life Benefits from Insurance may be Taxable, 21
TAX'NFORLAW. 86, 86 (1992) (stating that major medical and hospitalization plans will pay some,
but not all, of the medical expenses associated with prolonged hospitalization).
226 U.S.C.A. § 101(g)(4)(A) (1997) (terminally ill individuals are those who are certified
by a physician as having an illness or physical condition which can reasonably be expected to
result in death in twenty-four months or less after the date of certification).
'26 U.S.C.A. § 101(g)(4)(B) (1997) (chronically ill individuals are those described by
section 26 U.S.C.A. § 7702B(c)(2) (1997), except that such term shall not include a terminally ill
individual as having been certified by a licensed health care practitioner within the preceding
twelve month period (i) as being unable to perform (without substantial assistance from another
individual) at least two activities of daily living for a period of at least ninety days due to a loss
of functional capacity; or (ii) as having a level of disability similar (as determined under
regulations prescribed by the Secretary of Health and Human Services) to the level of disability
described above; or (iii) requiring substantial supervision to protect such an individual from threats
to health and safety due to severe cognitive impairment).
4Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110
Stat. 1936 (codified in scattered sections of 29 U.S.C., 42 U.S.C., 18 U.S.C., 26 U.S.C.); see also
Russell J. Herron, Note, Regulating iatical Settlements: Is the Invisible Hand Picking the
Pockets of the Terminally 17, 28 U. MICH. J.L. REF. 931,941 (1995) (stating the portion ofHPAA
relating the tax-free treatment of accelerated death benefits and viatical settlements was initially
proposed by Sen. Kassenbaum as part of the Republican Contract with America Tax Relief Act
DEPAUL JOURNAL OF HEALTH CARE LAW [Vol. 1:773
Effective January 1, 1997, certain portions of the HPAA grant
terminally or chronically ill individuals with life insurance policies a
reprieve from the harshness of their illness5 by offering a tax-free
disbursement of the policy benefits while still living.6 Although ordinarily
reserved for the survivors of the insured, life insurance benefits are often
needed by the policyholder to finance current needs.' When such benefits
are distributed directly by an insurance carrier, they are called Accelerated
Death Benefits (ADBs). 8 When a third party regularly engaged in the
purchase or assignment of such policies makes the distribution, the
distribution is called a "viatical settlement." 9
Prior to the enactment of the HPAA, such pre-death distributions
were taxed as if they were gross income to the recipient."° Thus, other
sources of money such as home equity loans or loans from relatives were
a more appealing method for obtaining needed funds." As a result of
I-PAA, industry experts have speculated that tax-free treatment will make
of 1995).
-26 U.S.C.A. § 10 1(g) (1997).
6See generally id. (previously such pre-death disbursements were considered gross income
and were taxed at ordinary income rates which effectively reduced the total income to the
recipient).
'See Wesley S. Caldwell, et al., Innovation and Controversy: iatical Arrangements and
Accelerated Death Benefits, 172-NOV J.J. Law. 39, 39 (Oct./Nov. 1995) (stating that the insured
occasionally has a greater need for the policy's benefits than her beneficiaries); see also Sullivan,
supra note 1, at 86 (stating that disability income generally is not enough to cover everyday
expenses and medical expenses not covered by an employer's policy).
sHerron, supra note 4, at 971; see also Ronald S. Ross, Accelerated Death Benefits Tax
Treatment Eased, 23 TAX'N FOR LAW. 229, 229 (1995) (stating that an accelerated death benefit
generally allows a life insurance policy holder to receive some or all of the death benefits before
death).
9See Caldwell, supra note 7, at 41 n.1 (explaining "viatical" is from the Latin word
viaticum, which defined the money and supplies given to a traveler or Roman soldier before a long
journey or adventure. Viaticum is also the name of the host given to a communicant during the
Roman Catholic sacrament of extreme unction); see also John F. Blake, Life Insurance Procecds
Can be Received Tax Free Prior to Death Under New Prop. Regs, 79 J. TAX'N 156, n.3 (1993).
"OSee 26 U.S.C.A. § 61(a) (1997) (gross income means all income from whatever source
derived.); cf. Ross, supra note 8, at 229 (stating that benefits paid even one minute before death
are taxed as gross income, with the exception of the policyowner's investment in the policy); but
see 26 U.S.C.A. § 101(a)(1) (1997) (the proceeds of a life insurance policy are not included as
gross income if they are paid by reason of death of the insured).
"David Flaum, Money-Tax Law Changes May Ease Medical Expenses, COM. APPEAL
(Memphis), Jan. 5, 1997, at Cl.
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viatical settlements and ADBs a viable estate-planning tool for the
terminally and chronically ill.'2
Unfortunately, due to the nature of viatical settlements and ADBs,
and the restrictions imposed and the uncertainties caused by HPAA, its
intended usefulness is limited. This article summarizes and analyzes the
portion of I-PAA relating to the tax treatment of ADBs and viatical
settlements. It also provides information on the industry and concludes
that while there is extreme opportunity for growth in the industry, HPAA
will not make ADBs or viatical settlements a viable option for every
terminally or chronically ill patient.
BACKGROUND
In 1988, viatical settlements and ADBs were virtually non-existent.' In
response to the Acquired Immune Deficiency Syndrome (AIDS) epidemic,
companies called Viatical Settlement Providers (VSPs) emerged offering
AIDS patients pre-death disbursements in exchange for a beneficial
interest in the patients' life insurance policies. 4 Shortly thereafter, many
life insurers began offering ADB options to compete with the increasing
popularity of viatical settlements.' s Although similar in effect, viatical
2Life Insurance: Health Reform Lm Makes iaticals More Attractive For Terminally 11,
BNA HEALTH CARE DAIy, Sept. 20, 1996, at dlO [hereinafter Life Insurance]; sce also Lynn
Asinof, Maaking Strides: Tax Change Could Make Life Easier For People i'th Chronic or
Terminallllness, CM. TRhI., Oct. 4, 1996. (stating that the new law makes viatical Ec-tlemntu and
accelerated death benefits a much better deal).
"Jennifer Berner, Beating the Grim Reaper, or Just Confusing Htm9 Eamining the
HarmfulEffects of Viatical Settlement Regulation, 27 J. MARSHALL L. REv. 531, 5,3 (1994; see
also Caldwell, supra note 7, at 39 (claiming that viatical arrangements were first offered in 1989
by Miami-based Living Benefits, Inc.); but see Abbie Crites-Lenoni & Angelic S. Chen, Moncy
for Life: Regulating the Viatical Settlement Industny 18 J. LEGAL MED. 63, 65 (1997) (claiming
that Living Benefits Inc., of Albuquerque, New Mexico was the first VSP, purchasing its first
policy in 19S9); Cf Malcom E. Osborn, Rapidly Developing Laiv on Viatical Settlements, 31
VAx FopsrL. REV. 471,495 n.6 (1996) (stating that Europeans have used viancal settlements
before they were developed in the United States).
4See Steven L. Severin & Stephen R. Corrick, Sale Treatment for Vialical Settlements of
Life Insurance, 82 J. TAX'N 35, 35 (1995) (stating that the AIDS epidemic is the primary cause of
the growing interest in viatical settlements and accelerated death benefits); see also Bemer, supra
note 13, at 583 (stating that the viatical settlement market emerged in response to the high cost of
living with AIDS).
"See Caldwell, supra note 7, at 39. But see Dennis J. Nirtaut, Ask a Benefit Manager"
Living Benefits Can Offer Flexibiliy and Security, CRAIN's BUS. IS., May 22, 1995, at 23
(estimating that although not widespread, as many as 25 percent of employers' life insurance plans
1997] 5
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settlements and ADBs differ in many respects. These inherent differences
and the lack of industry regulation have caused critics of HPAA to
complain that it is too easy for VSPs to exploit patients duing their most
vulnerable moments.' 6 Many states, however, have recently adopted
legislation to regulate viatical settlements, which greatly diminishes the
possibility for fraud or abuse.' 7 Despite the controversy, many terminally
ill patients have found ADBs and viatical settlements to be a functional
means of acquiring needed cash. As word spreads of these options, 19
practitioners will increasingly be called upon to answer their clients'
questions regarding the sale or assignment of life insurance policies.
Viatical Settlements
Viatical settlements are created when a terminally ill policy holder
(Viator) assigns or sells her interest in a life insurance policy to a VSP in
exchange for an immediate cash settlement worth less than the face value
of the policy.19 Upon receipt, the Viator may use the proceeds of the sale
to pay medical bills, housing costs, or to do virtually anything she
wishes.20 Once the policy is sold or assigned, the VSP names itself as the
may have ADB provisions in them and interest in such plans is increasing); Cf Brian R. Ball, Pre-
Death Benefits Shift as AIDS Fades, BUSINESS FIRST OF COLUMBUS, vol. 13, Iss. 40 (May 30,
1997) (stating that 25 percent of universal and variable life policies now have a-celerated benefits
riders, while only 5 percent of all life insurance policies now have them).
'
6See Herron, supra note 4, at 968-969 (noting that these people are probably undergoing
greater stress than they have ever experienced, and that the unequal bargaining power of viatical
settlements is a powerful source of exploitation).
"At least 20 states currently have some form of legislation regulating the viatical industry
(California, Connecticut, District of Columbia, Florida, Illinois, Louisiana, Michigan, Minnesota,
Mississippi, New York, North Carolina, North Dakota, Ohio, Oregon, Texas, Utah, Vermont,
Virginia, Washington, and Wisconsin) and 11 states currently have viatical regulation legislation
pending (Alabama, Arkansas, Delaware, Hawaii, Maine, Massachusetts, Missouri, Montana, New
Hampshire, Pennsylvania, and South Carolina) [hereinafter State Legislation].
"Terminally 11l Using Insurance Policies to Enhance Life, SALT LAKE TIB., Sept. 7, 1997,
at B2 (noting that popular actor, Robert Urich, has just become a spokesperson for Utah-based
"Lifewise" to share his story of surviving cancer and promote the sale of life insurance policies).
"Herron, supra note 4, at 933; see also Shanah D. Glick, Are Viatical Settlements
Securities Within the Regulatory Control of the Securities Act of 1933?, 60 U. CMt. L. REV. 957,
964 (1993); see also Berner, supra note 13, at 584 (stating that a viatical se llement is when a
terminally ill person (Viator) sells her life insurance policy to a viatical settlement company or an
individual purchaser for a cash settlement).20Berner, supra note 13, at 616 n.4.
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beneficiary of the policy2' and usually assumes responsibility for paying
the policy premiums.22 Upon the death of the Viator, the VSP collects the
entire face value of the policy from the insurance company.' In many
instances, the VSP will profit from this transaction by collecting the
difference between the face value of the policy and the discounted
settlement amount, minus the administrative costs. If the discount on the
settlement is low enough and the administrative costs are reasonably
contained, the profit can exceed 40 percent.24
The amount of profit, however, is completely dependent on how long
the Viator lives. Since the return is fixed, the annualized rate of return
depends on the length of the investmentY If the Viator dies before the
predicted date, the VSP's profits will be greater than if the Viator dies
after the predicted date.26 If the Viator lives too long beyond the predicted
life expectancy, the VSP may incur a net loss because the amount of
discount built into the settlement may not be sufficient to cover the
continuing premium payments on the policy.27  Therefore, since the
calculation of the disbursement is integrally tied to the prediction of life
expectancy, an accurate diagnosis of the terminal illness is necessary to
insure a profitable transaction.
Because VSPs effectively wager on and profit from the lives of the
terminally ill, some complain that this is a "ghoulish industry" and have
2tSee Glick, supra note 19, at 965 (stating that after the purchase of the policy, the buyer
steps into the shoes of the former owner and assumes the right to name the beneficiary of the
policy).
'Bemer, supra note 13, at 5S4; but see Herron, supra note 4, at 957-958 (explaining that
viatical companies do not always need to incur this expense since many insurance companies offer
disability waivers for the premium payments. Under such provisions, the insurcd's employer
undertakes responsibility for the policyholder's premium payment- in the event that the
policyholder becomes disabled or unable to pay the premium. Usually, viatical companies will
encourage Viators to secure this waiver before viaticating. As a result, the Viator should receive
a larger distribution and the viatical company will not have to take over payment of the premiums
and will thus not bear the risk that the Viator will live beyond her life expectancy).
'Herron, supra note 4, at 933.
24See id. at 935 (stating that profits sometimes exceed 40 percent of the face value of a
policy); but see id. at 946 (stating that according to the best estimate, viatical settlement
companies average 20 percent in profits on any policy).
'SEC v. Life Partners, Inc., 898 F. Supp. 14 (D.C. 1995), vacatcd by S7 F.3d 536 (D.C. Cir.
1996), reh'g denied 102 F.3d 587 (1996).
'
6Caldwell, supra note 7, at 39.271d.
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complained that such arrangements are essentially "death futures." 28
Nonetheless, viatical settlements seem to be gaining acceptance; for
example, some banks are now offering viatical settlement investment
options.29 By allowing investors to spread the risk of loss among several
different Viators, such banks are essentially selling viatical settlement
"mutual funds." 30
Although morbid to some, similar arrangements have been available
for many years and liquidating virtually any asset a person owns may
create such a death future.3' Recently, for example, "reverse mortgages"
have become a popular way for the elderly to remain in their homes after
retirement. Similarly, a seller could enter into a sale-leaseback
arrangement or could sell her home subject to a life estate in the
property.33 Alternatively, a buyer could "factor" a seller's "account
receivables" to accomplish the goal of cashing out one's assets before
death.34
Nonetheless, since a VSP's profit margin is wholly related to the life
expectancy of the Viator, concern has arisen over the possibilities for
fraud and abuse in the industry.35 Seeking tighter control on the industry,
the Securities and Exchange Commission (SEC) recently fought and lost
a lengthy battle that sought to classify viatical settlements as securities. 36
Such a classification would cause viatical settlements to :Fall under the
'See Herron, supra note 4, at 936; Nirtaut, supra note 15, at 23; see also Caldwell, supra
note 7, at 39 (stating that the detractors of viatical settlements refer to them as death futures).
'Are Banks Ready to Market Viatical Settlements?, BANK MuTUAL FUND REP., June 9,
1997, at vol. 5, no. 23 (indicating that Suburban Federal Bank near Chicago started selling viatical
settlements in late 1996).
"Michelle DeBlasi, Viaticals Breathe New Life in Banks?, BANK INVESntENT MARKETING,
Sept. 1, 1997 (claiming that investors can diversify their investments to reduce the risk of loss by
investing in a virtual "mutual fund" of viatical settlements).
"See Osbom, supra note 13.
"Celeste M. Hammond, Reverse Mortgages: A Financial Planning Device For The Elderly,
I ELDER L.J. 75 (1993) (explaining how, under such arrangements, an individual with equity in
his/her home is loaned money and may receive advances from a lender with no expectation of
repayment until the death of the borrower).
"SEC v. Life Partners, 898 F. Supp. 14, (D.C. 1995), vacated by 87 F.3d 536, 542 (D.C.
Cir. 1996), reh'g denied 102 F.3d 587 (1996).
4 Id.
"Herron, supra note 4, at 935; see also Bemer, supra note 13, at 583 (stating that the
market was open to abuse by viatical companies who could take advantage of vulnerable victims).
"SEC, 87 F.3d at 536.
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regulatory authority of the SEC. 7 Ruling that profits of the VSP are not
related to the work of the VSP, but rather, the death of the Viator, the
court concluded that viatical settlements are not securities. -3
Consequently, those investing in viatical settlements will not be afforded
the protections granted under the Securities Act of 1933 that were
designed to require disclosure of material information and to prevent
misrepresentation, deceit, and fraud in the sale of securities.39
Acknowledging the need for consumer protectionl" many state
legislatures have enacted legislation to regulate the viatical industry.4'
However, much of the legislation is presently aimed at protecting the
Viator, rather than the VSP or investor in viatical settlement products. In
addition, the National Association of Insurance Commissioners (NAIC)42
has created the Viatical Settlements Model Act (Model Act) and the
Viatical Settlements Model Regulation (Model Regulation). The NAIC's
Model Act emulates California's viatical settlement statute4 3 and the
NAIC has expressed its desire that other state legislatures adopt similar
provisions."' Currently, twenty states have adopted some form of viatical
settlement regulations4 and eleven states are now considering such
legislation.4 6 These provisions call for the licensing of VSPs, require
disclosure of certain information to the Viators, and grant the authority to
impose minimum payout standards for viatical settlements."
"Timothy P. Davis, Should Viatical Sclentcnts be Considered "Sccurilts" Under the
1933 Securities Act?, 6 KANSAS LL. & PUB. POL'y 75,76 (Winter 1997).
" SEC v. Life Partners, Inc., 89S F. Supp. 14, (D.C. 1995), vacated ky 87 F.3d 536, 549
(D.C. Cir. 1996), reh'g denied 102 F.3d 5S7 (1996).
39Davis, supra note 37.
4"See Berner, supra note 13, at 5S6 (stating that several states have responded to concerns
over the possibilities for abuse, such as overreaching and undue influence upon vulnerable victin,
and that such legislation seeks to protect the Viators).
41See State Legislation, supra note 17.
42See Osborn, supra note 13, at 474 (concluding that since viatical settlements involved the
business of insurance, the National Association of Insurance Commissioners ("NAIC") adopted
the Viatical Settlements Model Act and the Viatical Settlements Model Regulation).431d.
44See id. (stating that several states have adopted insurance laws regulating viatical
settlements, many of which seem to be based on the Model Act of the NAIC).45See State Legislation, supra note 17.4
'1d.
47VIATICAL SurrLEMENTS MODEL ACT (National Ass'n of Ins. Comm'rs 1994), reprinted
in 4 NATIoNAL ASS'N OF INS. COMI'RS, MODEL LAWS, REGULATIOS AND GUIDELiWES 697-1 to
697-1S, 697-1, §§3, 8, 10(B) (1995) [hereinafter Model Act].
1997] 779
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Viatical Settlement Model Act and Model Regulation
Essentially, the Model Act requires viatical settlement agreements to be
evidenced by a written contract4 8 and for such contracts to be filed with
and approved by the appropriate state department of insurance. The
Model Act also imposes strict licensing requirements for VSPs and gives
the state department of insurance the power to revoke the license after
issuance.5 In addition, VSPs must file annual statements with the
department of insurance and allow access to all viatical set:lement records
upon request.5
Before signing a viatical agreement, VSPs are required to disclose the
ramifications of selling a life insurance policy to the potential Viators5
Among the many required disclosures, VSPs must inform potential
Viators of:
1) the alternatives to viatication, including but not limited to ADBs;
2) some or all of the proceeds may be taxable and that assistance should be
sought from a personal tax advisor;
3) viatical settlements could be subject to claims by creditors;
4) the receipt of the viatical settlement may adversely affect the recipient's
eligibility for Medicaid or other government benefits, and thus advice
should be sought from the appropriate agencies;
5) the policy owner has a right to rescind the viatical settlement contract
within thirty days of execution of the contract or within fifteen days of
the receipt of the viatical settlement proceeds, whichever is sooner; and
6) the date the funds will be available to the Viator and the source of those
funds. 53
4
'Osborn, supra note 13, at 484.491d
'Old. at 475.
SModel Act, supra note 47, at 697-1 §7(B) (although the insurance Commissioner may
examine the records of the viatical settlement company, the names and individual identification
data for all Viators shall be considered private and confidential information and shall not be
disclosed by the commissioner, unless required by law).
"See id. (actually, the disclosure must be made no later than the date tho viatical settlement
is signed by all parties); but see Herron, supra note 4, at 943 (criticizing the disclosure period as
being so late in the viatication process that it makes the Viator unlikely to pull out and explore
other options).55Model Act, supra note 47, at 697-1 §8; see Osbom, supra note 13, at 476-477.
780 [Vol. 1:773
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Moreover, before the contract is signed, VSPs must obtain a written
statement from a licensed physician certifying the insured's sound mind
and lack of undue influence.5 4 In addition, the VSP must obtain a
witnessed document from the insured that:
1) acknowledges the catastrophic or life-threatening condition of the insured;
2) represents that she fully understands the viatical settlement contract and
the ramifications of selling the policy;
3) consents to the viatical settlement contract and professes her free will in
entering the agreement; and
4) releases her medical records to the VSP.S
Finally, the NAIC Model Act permits the insurance commissioner of each
state to promulgate regulations implementing the Model Act and to
specifically establish standards of reasonableness for viatical settlement
disbursements. 56
In addition to the requirements set forth by the Model Act, the Model
Regulation establishes guidelines governing the minimum amounts to be
paid to a Viator. Based on an estimate of the insured's life expectancy,
the minimum discount percentages as stated in the Model Regulation are
as follows:
1) less than six months to live equals 80 percent;
2) at least six, but less than twelve months to live equals 70
percent;
3) at least twelve, but less than eighteen months to live equals
65 percent;
4) at least eighteen, but less than twenty-four months to live
equals 60 percent; and
5) twenty-four months or more to live equals 50 percent.
According to the Model Regulation, these minimum percentages
may be reduced by 5 percent if the policy is written by an
5Model Act, supra note 47, at 697-1 §9(A)(1).
"See Osborn, supra note 13, at 477 (describing the consent and witness requirements for
Viators).
6See id. at 478 (describing the authority granted by section 10 of the Model Act to
promulgate regulations).
1997]
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insurance carrier rated less than the highest four categories by
A.M. Best, or a comparable rating by another rating agency. 7
The Model Regulations also specify numerous licensing requirements
for viatical settlement providers and brokers.58 Furthermore, the Model
Regulation identifies specific information to be included in an annual
report to the insurance commissioner, such as the date of viatication,
amount disbursed, face values of the policies, and life expectancies for
each Viator.59 Finally, the Model Regulation imposes strict advertising
standards on VSPs that mandate the publication of the average speed of
viatication and the average disbursement percentage if the advertisement
emphasizes the speed or payment rates of viatication.6" However, since
the Model Regulations and the Model Act have not been universally
adopted, individuals should contact their state insurance commissioner to
determine the extent of viatical regulation.
Viatical Industry Controversy
Despite the proposed regulations or legislation enacted, opponents have
been troubled by the nature of the industry and the potential for abuse.61
At least one commentator has suggested that the industry has created the
danger of "hit men" being hired to guarantee large profit margins by
terminating the insured's life.62 In addition, since settlement payouts are
5TNational Ass'n of Ins. Comm'rs, 1994-2 NAIC Proe. 549, 573 (§4) [hereinafter "1994-2
NAIC Proc. 549"].SId. at 572-573 (§§ 1, 2)
"
9Id. at 572-573 (§ 5 - Reporting Requirement). On March 1 of each calendar year, each
viatical settlement provider licensed in this state shall make a report conta ning the following
information for the previous calendar year: (A) For each policy viaticated: (1) Date viatical
settlement entered into; (2) Life expectancy of the Viator at the time of contra-.t; (3) Face amount
of the policy; (4) Amount paid by the viatical settlement provider to viaticate the policy; and (5)
If the Viator has died: (a) Date of death; (b) Total insurance premiums paid by viatical settlement
provider to maintain the policy in force; (B) Breakdown of Applications Received, Accepted and
Rejected, by Disease Category; (C) Breakdown of Policies Viaticated by Issuer and Policy Type;
(D) Number of Secondary Market vs. Primary Market Transactions; (E) Portfolio Size; and (F)
Amount of Outstanding Borrowings.
6Od. at 572-573 (§ 6(H) - Advertising Standards).6 Playing Field in "Death Futures" Can be Slippery, PLAIN DEALER, May 5, 1997 (stating
that to guard against fraud, experts suggest checking out viatical companie,; with the National
Viatical Association at (800) 741-9465, or the Viatical Association of America (800) 842-9811).
62Denise M. Schultz, Angels of Mercy or Greedy Capitalists? Buying Life Insurance
Policies from the Terminally ll, 24 PEPP. L. REv. 99, 105 (1996).
(Vol. 1:773782
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usually only worth 50 to 80 percent of the value of the life insurance
policy,63 some commentators complain that these discounted settlements
translate into profits that are disproportionate to the risks associated with
viatication.6 Proponents of viatical settlements, however, claim the risks
associated with viatication justify the calculation of low distribution
percentages.6 5 Since the failure to accurately assess these variables could
result in diminished profits or even a net loss to the VSP, proponents
argue that large discounts are necessary to offset potential losses.
5
Among the considerations, VSPs must evaluate the stability of the
insurance carrier because of the risk that the insurer could become
insolvent or otherwise default on its obligation under the policy.67 In
addition, VSPs must bear the risk of rising interest rates after negotiation
of the settlement, which would effectively increase the cost of their
borrowed capital. 6S Furthermore, VSPs must consider the possibility that
a life-prolonging treatment or cure for the terminal illness might result in
a diminished return or net loss.6 9 Similarly, a VSP must accept the danger
that the Viator could simply outlive a physician's best estimate of life
expectancy.7" Viatical companies must also face the risk that ex-
beneficiaries might attempt to enforce their previously released rights,
thus resulting in costly litigation." Finally, the VSP must accurately
estimate the administrative costs associated with viatication. Such costs,
'Bemer, supra note 13, at 584; see also Glick, supra note 19, at 964-965 (stating that the
fixed sum payment reflects the buyer's estimation of the present value of the policy's future
money claim, discounted by both the premiums the buyer expects to pay and the risk that the seller
will live longer than expected).
'See Herron, supra note 4, at 958 (claiming that the profits enjoyed by viatical companies
are disproportionate to the risks and costs incurred and that such profits cannot be explained
wholly on those bases).
65See id. at 950 justifying the low payouts of viatical companies by pointing to the
substantial risks associated with viatication).
6"Id. at 950-51.
67See id. at 954 (showing that an insurance company default will leave the viatical company
with a valueless policy).
"Schultz, supra note 62, at 104.
"See Herron, supra note 4, at 955.7
°See id. at 950 (stating that the cost to viatical companies can be quite substantial if the
Viator outlives the company's life expectancy prediction).
7Lee Ann Dean, Note, Acquired nmmune Deficiency Syndrome, Jiatical Sc!tcincnt, and the
Health Care Crisis: AIDS Patients Reach Into the Future to Make Ends Mcct, 25 RuTGEP.S LJ.
117,142 (1993).
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including policy premium payments, mailing and telephone expenses,
legal fees, and costs resulting from the physician's examination of the
Viator,72 may exceed $3,000 per policy.73
Accelerated Death Benefits
Unlike viatical settlements, ADBs are paid directly from the life insurance
carrier and cost the recipient very little.74 When first introduced, insurance
companies touted the option as the alternative that would make viatical
settlements obsolete.75 The ADB option has failed to live up to such
expectations because ADBs are only available to the policy holder if the
option was originally written into the policy or if the benefit was made
available through a rider.76
In addition, most insurers offering ADBs require certain conditions
to be met before a disbursement will be made. Traditionally, a physician's
diagnosis that the insured has twelve 12 months or less to live has been
required by insurers for disbursement to commence. 77  Viatical
arrangements, on the other hand, generally do not require such a
prognosis; 7 and unfortunately, by the time a person has less than twelve
months to live, he or she may be virtually immobile or unable to enjoy all
of the benefits of an accelerated policy. Therefore, because a terminally
ill person may wish to collect the living benefits while still able to enjoy
them, ADBs are not always an effective option.
72Herron, supra note 4, at 957.
7'See Carole C. Lamson, Legal Introduction to Living Benefits in Life Insurance: New
Perspectives and Developments, N.Y. ST. B.J., Nov. 1993, at 16 (stating that some have placed the
average administrative costs for viatication at $3,000 per policy).
74Herron, supra note 4, at 972.
'SId. at 971.761d. at 971-972; see also Nirtaut, supra note 15, at 23 (estimating that as many as 25
percent of employers may have an ADB provision in their life insurance plans); Cf Ball, supra
note 15 (stating 25 percent of universal and variable life policies not have accelerated benefits
riders, while only 5 percent of all life insurance policies now have them).
'Caldwell, supra note 7, at 2; see also Herron, supra note 4, at 973 (stat;ng that 67 percent
of companies offering accelerated benefits require the policyholder to have a life expectancy of
less than one year before benefits will be accelerated. Moreover, 30 percent require a life
expectancy of less than six months before benefits will be accelerated).78SEC v. Life Partners, Inc., 898 F. Supp. 14, 18 (D.C. 1995), vacated by 87 F.3d 536 (D.C.
Cir. 1996), reh'g denied 102 F.3d 587 (1996) (although the standard viatical settlement is made
to people with life expectancies of twenty-four months or less, other offerings allow investors to
select the policies of Viators expected to live longer than two years).
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Moreover, many ADB options restrict the percentage of the policy's
face value that may be accelerated.79 Typically, acceleration of up to 50
percent of the value of the policy is all that is allowedO In addition,
ADBs have generally been available only on whole life policies,8 ' while
viatical arrangements are generally available for any type of life insurance
policy, including term life policies.82
As a result, the conditions and restrictions imposed on such ADB
benefits have prompted at least one commentator to claim they are only
preferable to viatical settlements in limited instances. 3 Not only must the
insured have the ADB option available, and have less than one year to
live, but also the insured's financial needs must be satisfied by whatever
accelerated benefits are permitted under the acceleration clause. 4
ADBs do, however, offer advantages that viatical settlements cannot.
Unlike viatical settlements, accelerated benefits cost the policyholder very
little.s5 Additionally, the unaccelerated remainder of the policy, minus
applicable fees, is generally preserved for the named beneficiaries upon
the death of the insured. 6 In the viatical arrangement, no such option is
available since the VSP is assigned the entire face value of the policy.
LEGAL TREATMENT OF ADB AND
VIATICAL SETTLEMENTS
Although traditionally marketed to Human Immunodeficiency Virus
(HIV) and AIDS sufferers, viatical settlements and ADBs have been, and
7-Herron, supra note 4, at 973 (stating that only 25 percent of companies offering
acceleration impose no limit, while 59 percent of companies limit the accelerated portion to no
more than 50 percent of the policy's face value).
sold.
"'Caldwell, supra note 7, at 2.
8'd.
OHerron, supra note 4, at 974.
"Id.
"'Id. at 972.
5ld. at 974; but see Schultz, supra note 62, at 105 (noting that most viaticators are
homosexual males without dependents or the need to preserve their life insurance benefits).
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are increasingly used by those suffering from other terminal illnesses.8 7
At one time, nearly 90 percent of all viatical arrangements involved AIDS
patients, while the remainder was largely comprised of terminally ill
cancer patients. 88 As word has spread of the availability of the financial
options, those suffering from heart disease, alzheimer's disease, and
amyotrophic lateral sclerosis (ALS), also known as Lou Gehdig's disease,
have shown considerable interest in viaticating their life insurance
policies.8 9
Today there is some evidence that the creation of viatical settlements
for HIV/AJDS sufferers is diminishing.90 Encouraging medical news from
the l1th International AIDS Conference in Vancouver, Canada, regarding
the efficacy of new drug treatment, has caused one of the nation's largest
viatical settlement companies to stop buying policies from AIDS
patients.91 Among the discoveries, physicians have found that protease
inhibitors significantly diminish the spread of HIV in clinical trials.9 2
Some believe that these drug cocktails may transform AIDS into a
manageable chronic disease. 93 As a result of this life-prolonging AIDS
discovery, industry experts predict that the growth of the viatical industry
will likely come from servicing people with other diseases.94 Among
those considered desirable Viators are elderly diagnosed with life-
threatening diseases such as cancer, heart disease, Alzheimer's disease,
87See Matt Roush, Accelerated Death Benefits are Alive and Well, CRAI'S DETROIT Bus.,
Oct. 28, 1996 (stating that AIDS patients currently make up about 80 percent of the accelerated
benefits business, but that a year from now they are expected to only make up 50 percent of the
client base).
381d.
891d.
90See Lauren Chambliss, Business Day: How Making Money Out of Death is Dying Out,
THE EVENING STANDARD, Oct. 23, 1996 (stating that new treatments for AIDS have very nearly
killed the viatical industry that was making tidy profits from death).
91See Kathy M. Kristoff, Consumer Checklist/Your Money Servicing Terminally Ill, L.A.
TiEs, Sept. 13, 1996, at D3 (reporting the medical news that protease inhibitors significantly
stem the progression of AIDS in clinical tests); see also Chambliss, supra note 90 (stating that a
new class of drugs is extending the lives of the HIV-infected, wrecking the actuarial tables on
which the viatical industry is based).
92Kristoff, supra note 91; Chambliss, supra note 90.
9 Jane Bennett Clark, New Weapons Against AIDS- At a Price: The Latest Treatments Cost
Up to $20,000 a Year, KIPLINGER'S PERS. FIN. MAG., Feb. 1, 1997, at 102 (Managing Money:
Health & Fitness).
94Kristoff, supra note 91.
786 [Vol. 1:773
SE7J'LEMTAND DEATH BENEFITLA T
stroke, or ALS.9' In addition, others with certain pulmonary conditions,
chronic kidney disease or liver failure are also considered viable
candidates for viatication. 6 Some companies are now even selling
viaticals to anyone over age eighty-three.97 However, since protease
inhibitors do not help everyone and can cost as much as $20,000 per year
to administer, EIY/AIDS patients may still be in need of medical funds
since most health insurance plans limit medication reimbursement as well
as medications to those included on a specific approved list."
Until now, a significant drawback to ADBs or viatical settlements
was that such disbursements were considered gross income and thus taxed
at ordinary income rates. 9' In a 1994 Private Letter Ruling, the Internal
Revenue Service (IRS) considered whether the sale or assignment of a life
insurance contract is a taxable event.'"0 In this instance, the taxpayer
argued such an assignment of a life insurance policy should be excluded
from gross income under section 101 (a)(1) of the Internal Revenue Code
(Code)"'1 because all amounts received under a life insurance contract are
tax-free if paid by reason of the death of the insured.
However, because the patient-taxpayer had not yet died, the IRS
ruled the amounts received were not considered by reason of the death of
the insured. In support of its conclusion, the IRS reasoned that an
assignment of a life insurance contract for consideration is a sale or
exchange of property under section 1001(b).'0 z Hence, because gross
income includes all income from whatever source derived,0 3 including
95Crites-Lenoni, supra note 13, at 67.
551d.
9"Id
"Clark, supra note 93.
Kristoff, supra note 9 1; see also Life Insurance, supra note 12, at dl 0; sce also Thomas
IV. Johnson, Viatical Firms Report 30Oo Surge in Sales, FINANCIAL PL.,,NNG , May 1, 1997
(citing William E. Kelley, Executive Director of the Viatical Association of America, explaining
that viatical companies which have not tapped into the "mainstream" terminal disease market are
experiencing only modest growth).
l&'Priv. Ltr. Rul. 94-43-020 (1994).
"'See id.; see also, 26 U.S.C.A. § 101(a) (1997) (excluding from gros income, all amounts
paid under a life insurance policy if paid by reason of death of the insured).02Id.
1026 U.S.C.A. § 61(a) (1997).
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gains from the sale of property, '4 viatical and ADB disbursements must
be taxable.
Although the private letter ruling was not a legal precedent per se,O5
it was viewed as a serious deterrent for some people considering
viaticating their life insurance policies. 6 Of those who did viaticate,
some simply never reported the income on their tax returns knowing the
companies that buy life insurance death benefits typically do not send
1099 forms to the recipients or to the IRS." 7 As a result of the HPAA,
recipients may no longer need to be concerned about the federal tax
implications of receiving ADBs or viatical settlements. However, it is
important to recognize that every personal situation is unique and there are
still numerous considerations0 8 that an insured must evaluate before
selling, assigning, or accelerating her policy."9
26 U.S.C.A. § 101(g) Treatment of Certain
Accelerated Death Benefits
Under HPAA, section 101 of the U.S. Code (relating to certain death
benefits) is amended by adding section (g): Treatment of Certain
Accelerated Death Benefits. Included as part of section (g) is sub-section
(2), which specifically addresses the "Treatment of Viatical
1426 U.S.C.A. § 61(a)(3) (1997).
'
05See 26 U.S.C.A. § 61 10j)(3) (1997) (a private letter rulings is directed only to the
taxpayer who requested it, and may not be used or cited as precedent).
"'See Life Insurance, supra note 12, at dlO (noting that in the past, people knew that the
IRS wanted to tax proceeds as regular income, thus people opted not to use viatical settlements
because they did not want to pay income taxes on the settlement).
1
°TAsinof, supra note 12; but see 26 U.S.C.A. 6050Q(A) (1997) (mandating that any person
who pays long-term care benefits shall make a return, according to the forms or regulations
prescribed by the Secretary, setting forth: (1) the aggregate amount of such benefits paid by such
person to any individual during any calendar year; (2) whether or not such benefits are paid in
whole or in part on a per diem or other periodic basis without regard to the expenses incurred
during the period to which the payments relate; (3) the name, address, and TIN of such individual;
and (4) the name, address, and TIN of the chronically or terminally ill individual on account of
whose condition such benefits are paid).
'
08Among the considerations, the potential Viator must detemnine whether such
disbursements are subject to state taxation. Although many states follow the federal law with
respect to such disbursements, some do not.
"'See Lynn Waldsmith, Insurers Widen Scope ofDeath Settlements: 8etter AIDS Therapies
Prompt Insurance Buyout Companies to Consider Cancer, Other Fatal Diseases, The Detroit
News, Feb. 9, 1997, at CI (noting that the interest on a bank loan may be less than the discount
one could receive on a life insurance policy).
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Settlements."10 Collectively, any pre-death distribution received under
a life insurance contract... on the life of an insured who is either
terminally"2 or chronically ill"3 shall be treated as an amount paid by
reason of the death of an insured." 4 Therefore, due to section 101(a)(1),
such pre-death disbursements shall be excluded from the gross income of
the recipient.
According to section 101(g)(4)(A), a "terminally ill individual" is
one who has been certified by a physician as having an illness or physical
condition which can reasonably be expected to result in death within
twenty-four months or less after the date of certification." 5 A "chronically
ill individual" is defined by section 101(g)(4)(B) as having the meaning
given by section 7702B(c)(2), except that such term shall not include a
"terminally ill individual." As such, a chronically ill individual is one
who has been certified by a licensed health care practitioner, within the
preceding twelve month period, as being unable to perform (without
substantial assistance from another individual) at least two activities of
daily living for a period of at least ninety days due to a loss of functional
capacity. Such daily activities include:
1) eating,
2) toileting,
3) transferring,
4) bathing,
5) dressing, and
6) continence." 6
An individual may also be deemed chronically ill if she is certified by a licensed
health care practitioner within the preceding twelve month period as having a
"026 U.S.C.A. § 101(g)(2) (1997).
111H.R. Conf. Rep. 104-736, July 31, 1996 (to qualify as an insurance contract for federal
income tax purposes, a contract must be a life insurance contract under the applicable state or
foreign law and must satisfy either of two alternative tests: (1) cash value accumulation test; or (2)
a test consisting of a guideline premium requirement and a cash value corridor requirement (26
U.S.C.A. 7702(a) (1997))).
26 U.S.C.A. § 101(g)(1)(A) (1997).
26 U.S.C.A. § 101(g)(1)(B) (1997).
1426 U.S.C.A. § 101(g)(1)(A), (B) (1997).
"526 U.S.C.A. § 101(g)(4)(A) (1997).
"626 U.S.C.A. § 7702B(c)(2)(A)(ii) (1997).
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level of disability similar to the level of disability described above, 117 or
requiring substantial supervision to protect such an individual from threats
to health and safety due to severe cognitive impairment.1"
This distinction between the chronically and terminally ill is made
because there are certain special rules which apply only to the chronically
ill. Under section 101(g)(3)(A), a chronically ill insured may not receive
tax-free pre-death disbursements unless certain conditions are met. First,
the distribution must be used to pay for the unreimbursed costs incurred
by the insured for "qualified long-term care services."'' 19 "Qualified long-
term services" are defined in section 101(g)(4)(C) as necessary diagnostic,
preventative, therapeutic, curing, treating, mitigating, and rehabilitative
services and maintenance or personal care services which: (a) are required
by a chronically ill person; 0 and (b) are provided pursuant to a plan of
care prescribed by a licensed health care practitioner.'
Second, for a chronically ill patient to be covered by HPAA, the
terms of the contract giving rise to such a payment of pre-death benefits
must also satisfy both the requirements of section 7702B(b)(1)(B),12 and
the requirements (if any) applicable under subparagraph (B) entitled
"Other Requirements."' 23 These provisions relate to the treatment of
qualified long-term care insurance contracts 2 4 and the consumer
protection provisions promulgated by the NAIC under the Long-Term
Care Insurance Model Regulation and the Long-Term Care Insurance
Model Act.125 In addition, a chronically ill individual must follow the
standards adopted by the NAIC which specifically apply to chronically ill
"
71d. (as determined under regulations prescribed by the Secretary of the Treasury in
consultation with the Secretary of Health and Human Services).
1 826 U.S.C.A. § 7702B(c)(2)(A)(iii) (1997).
p26 U.S.C.A. § 101(g)(3)(A)(i) (1997).12026 U.S.C.A. § 7702B(C)(1)(A) (1997).
12'26 U.S.C.A. § 7702B(C)(1)(B) (1997).
"226 U.S.C.A. § 101(g)(3)(A)(ii)(I) (1997) (under section 7702B(1), the term "qualified
long-term care insurance contract" means any insurance contract if... (B) such contract does not
does not pay or reimburse expenses incurred for services or items to the extent that such expenses
are reimbursable under title XVIII of the Social Security Act (42 U.S.C.A. § 1395 (1997)) or
would be so reimbursable but for the application of a deductible or coinsurance amount).
'2'26 U.S.C.A. § 101(g)(3)(A)(ii)(II) (1997).
12426 U.S.C.A. § 7702B(b)(1)(B) (1997).
1'26 U.S.C.A. § 7702B(g) (1997).
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individuals.126 Moreover, a chronically ill individual is required to follow
the standards adopted by the state in which the policyholder resides.'2 7
Finally, a chronically ill individual may receive only a limited pre-
death disbursement. Under section 101(g)(3)(D), payments of pre-death
tax-free disbursements are limited to that allowable under section
7702B(d), which limits per diem disbursements to the excess (if any) of
the greater of either: (1) $175 per day ($63,875 annually); 2 3 or (2) the
costs incurred for qualified long-term care services provided for the
insured 29 in excess of the aggregate payments received as reimbursements
(through insurance or otherwise) for qualified long-term care services. 30
However, since chronically ill individuals are limited to payments for the
unreimbursed costs for qualified long-term care services under section
101(g)(3)(A)(i), the maximum pre-death disbursement is limited to the
unreimbursed expense of the long-term care services. In the event that
such payments exceed this limitation, such excess shall be includable in
gross income.'
HPAA also specifically defines what is meant by a "viatical
settlement provider" and designates certain requirements that must be met
before one can conduct the business of viatication. Under HPAA, a
"viatical settlement provider" is any person regularly engaged in the trade
or business of purchasing, or taking assignments of, life insurance
contracts on the lives of terminally or chronically ill, provided that the
person meets certain conditions. 3 2 Generally, the person must be licensed
for the purpose of purchasing, or taking assignments of, life insurance
contracts in the state in which the insured resides. 3 3 However, if the state
in which the insured resides does not require a license for such activity,
12626 U.S.C.A. § 101(g)(3)(B)(ii) (1997).
'2726 U.S.C.A. § 101(g)(3)(B)(iii) (1997).
12826 U.S.C.A. § 7702B(d)(2) (1997) (limits the periodic dollar amount to the amount in
paragraph (4). Paragraph (4) characterizes the dollar amount as S 175 per day (or the equivalent
amount in the case of payments on another periodic basis). Paragraph (6) defines periodic
payments as payment (whether on a periodic basis or otherwise) made without regard to the e<tent
of the costs incurred by the payee for qualified long-term care services).
226 U.S.C.A. § 7702B(d)(2)(A)(ii) (1997).
3026 U.S.C.A. § 7702B(d)(2)(B) (1997).
1'26 U.S.C.A. § 7702B(d)(1)(B) (1997).
13226 U.S.C.A. § 101(g)(2)(B)(i) (1997).
"326 U.S.C.A. § 101(g)(B)(i)(I) (1997).
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the viatical settlement provider must meet certain explicit requirements
governing the care for the terminally or chronically ill set forth below.134
To viaticate a terminally ill person's policy when the insured's state
does not require licensing of the VSP, a VSP must meet the requirements
of sections eight and nine of the NAIC Model Act, 135 which involve the
disclosure, certification, and consent requirements described above. 36 In
addition, such unlicensed VSPs must follow the requirements of the NAIC
Model Regulations relating to the standards for evaluation of reasonable
payments in determining the disbursement amounts for the terminally ill
insured.'37 Since the NAIC currently does not distinguish between the
terminally or chronically ill in its standards for evaluation of reasonable
payments, a chronically ill Viator should be presumed to receive the same
reasonable payments as any other Viator.
ANALYSIS AND IMPACT
Effectively, this new law only partially increases the viability of viatical
settlements and ADBs as estate planning tools. Although HPAA allows
the exclusion of such disbursements from gross income, it does not go far
enough in creating real benefits for the terminally and chronically ill.
According to a recent study published by the JOURNAL OF THE AMERICAN
MEDICAL ASSOCIATION (JAMA), more than 100 million Americans live
with chronic conditions 38 and their direct health care costs account for
three-fourths of U.S. health care expenditures. 139 Including indirect costs,
the amount spent on chronic conditions in 1990 was a staggering $659
..26 U.S.C.A. § 101(g)(B)(i)(II) (1997).
326 U.S.C.A. § 101(g)(B)(ii)(I) (1997).
"
6See Osborn, supra note 13, at 477-78.
13'26 U.S.C.A. § 101(g)(B)(ii)(II) (1997); see 1994-2 NAIC supra note 57, at 698-1 (§ 4),
"'Catherine Hoffman, et al., Persons with Chronic Conditions: Their Prevalence and
Costs, 276 JAMA 1473, 1477 (1996) (defining "chronic condition" as being a self-reported
condition classified under the rules of the International Classification of Diseases, Ninth Revision
(ICD-9) and meeting the criteria of(1) being identified as an "X" code, as defined by the National
Medical Expenditure Survey (NMES) and National Health Interview Survey (NHIS) as an
impairment; and (2) if not an "X" code, then was a 3-digit ICD-9 code for a disease which is not
self-limiting, but creates persistent and recurring health consequences, lasting fcr periods of years
(not days or months). However, such a definition does not include conditions which may also be
acute, such as unspecified bronchitis).
"9Id. at 1476.
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billion dollars.14° Moreover, the study concluded that the majority of these
persons are not disabled nor are they elderly.' 41 Since some predict the
baby-boom population will live longer with chronic illnesses, 14 it should
be anticipated that expenditures for chronic conditions may increase
exponentially in the coming years.' 43 Consequently, health care reform
should be directed at curbing the growth of such expenses and
discouraging reliance on government assistance. Although chronic
sufferers seem to be the population most in need of financial assistance,
and the population most likely to rely on Medicaid or Medicare for such
aid, HPAA does little to address the needs of the chronically ill or to curb
their dependence on government assistance.
In contrast, increased viatication among terminally ill individuals
may theoretically cause a reduction in government reliance and an actual
growth in federal revenue. Assuming that terminally ill Viators pay for
their own medical expenses with their distributions, they will not need to
rely on Medicaid for their medical care. 144 In addition, since they will
likely pay full price for medical services, rather than the discounted
Medicaid rate, they will generate greater tax revenues. 45 Furthermore,
assuming such funds are used to pay caregivers, tax revenues from wages
will theoretically increase.146  Finally, since VSPs will presumably
generate more revenue and pay more taxes, some speculate -PAA could
generate as much as $390 million dollars for the federal government
between 1995 and 1999.147
In addition, HPAA does provide some consumer protection by
granting tax-free treatment only when licensed individuals make the
purchase or assignment of life insurance policies. Unfortunately, some
ambiguities in HPAA leave open opportunities for fraud and abuse. Even
141d. at 1477.
1411d. at 1477-78.
142S.B. Fowler, Health Promotion in ClronicallyIll OlderAdults, 29(1) J. NEUROSCI. NURS.
39, 39-43 (Feb. 1997).
43See Hoffman, supra note 13S, at 1478 (stating that the aging population ,ill result in
growing numbers of persons with chronic conditions requiring medical and long-term care so as
to have a significant absolute impact on health care use and expenditures).
'"See Crites-Lenoni, supra note 13, at 74.
14Sld.
14Id
147Id.
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though HPAA extends the marketability of such arrangements to those
with chronic illnesses such as Alzheimer's or Parkinson's disease, the
nature of chronic disease will severely limit the number of chronically ill
individuals who can benefit from HPAA.
Presumably, HPPA was designed to make money more accessible to
those with terminal or chronic illnesses.' 8 Non-taxable income provides
the freedom to travel, pay bills, or provide for loved ones after death.
Subject to their ability to enjoy the money, a terminally ill individual may
do virtually anything she wishes with the money she receives from such
a tax-free disbursement.
Chronically ill individuals are limited to using the money to pay for
unreimbursed, qualified long-term care and are restricted by a cap which
limits the total amounts distributable. 149  Therefore, chronically ill
individuals may not enjoy the money as much as someone who is destined
to die; instead, they are permitted to use the money only for services
which ease, yet prolong their misery. As a result, HPAA will not benefit
chronically ill individuals as much as it will the terminally ill.
Unfortunately, HPAA does not specify who will monitor how the
money is spent. Therefore, it is conceivable that a chronically ill
individual could use the money for any purpose. In addition, it is unclear
whether the money may be commingled into other accounts, because once
commingled, it is obviously very difficult to track precisely how the
money is spent. Because there is no provision that requires the insurance
company or VSP to pay for such long-term care services directly, the
insured receives such funds and is responsible for claiming them as gross
income. As a result, a chronically ill person can easily abuse the system
by depositing the money into her general account without reporting the
transaction to the IRS. 150
'
48See H.R. Conf. Rep. 104-350 (Nov. 16, 1995) (indicating that the intended definition of
chronically ill should include those with Parkinson's disease, Alzheimer's disea;e, or symptomatic
AIDS); see also Beyond the Minimum: How New Laws Affect Nest Eggs, Insurance, CI. TRIB.,
Oct. 6, 1996 (claiming that the tax benefits make this something where people with heart disease
or Alzheimer's or any condition will see a real alternative for handling their money at the end of
their lives).
'4926 U.S.C.A. § 101(g)(3)(A)(i) (1997) (however, pursuant to 26 U.S.C.A. § 7702B(d)(5)
(1997) the dollar amount limitation shall be adjusted for inflation in the calendar years after 1997
in the same manner as amounts are increased pursuant to section 26 U.S.C.A. § 213(d)(10)).
5
'But see 26 U.S.C.A. § 6050Q(a) (1997).
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Additionally, HPAA provides that a person must be certified by a
physician15 ' as being either terminally or chronically ill. The new law,
however, fails to state who is responsible for the physician certification.152
While it is presumed that the taxpayer is responsible for obtaining such a
certification, viatical settlement providers may still encourage potential
Viators to visit "viatication friendly" physicians. Although such
fraudulent certification may jeopardize a physician's license, the lure of
considerable fees paid for such services may be enough to persuade some
unscrupulous physicians to embellish their diagnoses.5
While the new legislation extends the marketability of pre-death
arrangements to those with chronic illnesses, the definition of "chronic
illness" is so broad that it allows a wide range of individuals to qualify for
pre-death distributions. Clearly, the intent of this definition was to allow
those individuals with disorders such as Alzheimer's'5 or Parkinson's
disease to be able to take advantage of tax-free pre-death arrangements. 55
However, under the present definition, individuals with conditions such
as depression, asthma, or arthritis may be certified as having a chronic
illness which would entitle them to such tax-free pre-death benefits.
Although such conditions are often serious, they are usually manageable
by drug therapy and are usually not debilitating conditions that warrant the
acceleration or viatication of a life insurance policy.
In practice, however, the definition of chronic illness is effectively
irrelevant. Because the nature of the pre-death settlement industry
1526 U.S.C.A. § 101(g)(4)(D) (1997) (having the meaning given by section 1861(r)(I) of
the Social Security Act (42 U.S.C.A. § 1395x(r)(1) (1997)), HPAA defines a "physician" as a
doctor of medicine or osteopathy legally authorized to practice medicine and surgery by the State
in which he performs such a function or action).
"Life Insurance, supra note 12, at dlO.
'215 I.L.C.S. 158145 (1997) (noting that certain legislation prohibits VSPs from pkving
commissions, referral fees, or other compensation to physicians).
-'4Charlette Snow, Facing A1zheimer's Healthcare Issues; Medicare HMOs Dvezlop Plan
forFuture of Alzheimer'sProgramming, Modem Healthcare Special Rept, Sept 23, 1996, at 66
(estimating $S0 billion to $100 billion a year in costs associated with Alzheimer's diseas, making
it the third most expensive disease in the country, just behind heart disease and cancer. In
addition, the report indicates that in 1990, the average cost for professional home health care for
Alzheimer's patients was S12,572, 63% of which was paid out-of-pocket. For institutionalized
care, the annual average cost was $42,049 about 60% of which was paid out-of-pocket).
"See H.R. Conf Rep. 104-350 (Nov. 16, 1997) (indicating that the intended definition of
chronically ill should include those with Parkinson's disease, Alaheimer's dieaze, or synplonutic
AIDS).
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depends on the actual death of the insured, it is unlikely that most
chronically ill individuals (no matter how defined) would be granted a pre-
death disbursement of their policy. More importantly, even those with
Alzheimer's or Parkinson's disease will probably not benefit from this
HPAA. Because there are no accurate actuarial tables for the lives of
those with such disorders, it is too difficult to measure life expectancy,
and thus, too risky to accelerate or viaticate these policies. Therefore,
although HPAA's intent is to aid such individuals, the real effect will be
negligible.
If Congress had truly intended to assist those with terminal or chronic
illnesses through IHPAA, there are a number of other methods that could
have been employed to make cash more easily accessible. Since tax laws
serve the purpose of encouraging or discouraging behaviors, serious
efforts could have been made to reduce the burdens on the chronically ill,
their families, and both state and federal governments. To reduce the
burdens imposed on the government and the family of a chronically ill
individual, tax incentives which encourage home health care could be
provided to relatives or guardians of the chronically ill individual.
Although such incentives may have the short term effect of reducing
revenue, they would have the ancillary effect of reducing reliance on
programs such as Medicare.
In addition, Congress could have allowed terminally or chronically
ill individuals or their families a full deduction for all medical expenses,
not just those above 7.5 percent of the adjusted gross income. 6 Although
many terminally or chronically ill patients no longer work, and therefore
have little or no income, there are a number of functional chronically ill
individuals who would benefit from such a deduction. Again, such a
1626 U.S.C.A. § 213(a) (there shall be allowed as a deduction the expenses paid during the
taxable year, not compensated for by insurance or otherwise, for medical care of the taxpayer, her
spouse, or a dependent (as defined in section 152), to the extent that such epenses excecd 7.5
percent of adjusted gross income); 26 U.S.C.A. § 152 defines a "dependent" as any of the
following individuals over half of whose support ... was received from the taxpayer: (1) the son
or daughter of the taxpayer, or a descendant of either, (2) a stepchild of the taxpayer, (3) a brother,
sister, stepbrother, or stepsister of the taxpayer, (4) the parent of the taxpayer, or an ancestor of
either, (5) a stepfather or stepmother of the taxpayer, (6) a son or daughter of a brother or sister
of the taxpayer, (7) a brother or sister of the father or mother of the taxpayer, (8) a son-in-law,
daughter-in-law, father-in-law, mother-in-law, brother-in-law, or sister-in-law of the taxpayer, (9)
an individual who has their principal place of abode at the taxpayer's house and who is a member
of the taxpayer's household).
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deduction may initially decrease revenue, but such a loss in revenue could
be offset by requiring that the deduction be available only if it reduced
reliance on a government assistance program by the equivalent amount.
Finally, low interest federally insured loans collateralized by personal
property, real property, or life insurance policies could be made available
to chronically ill individuals. Again, such benefits would likely reduce
the reliance on the government for medical care assistance and may be an
effective means for individuals who lack family support to obtain
necessary funds.
Despite its faults, I-PAA will still benefit some individuals with
terminal illnesses who need immediate cash. Because tax-free treatment
is available only if the money is received from a qualified or licensed
viatical settlement provider, a strong consumer protection incentive to use
reputable representatives has been created. As a result, consumers with
terminal illnesses will benefit because viatical settlement providers vill
need to comply with regulatory standards in order to maintain eligibility
as "qualified viatical settlement providers."
CONCLUSION
In summary, only certain terminally ill individuals will significantly
benefit from HPAA. Because it has become more difficult to predict the
death of those with IHIV or AIDS, VSPs are now reluctant to viaticate
unless the individual's life has severely deteriorated. As a result,
llIV/AIDS sufferers should not expect to enjoy the benefits of these pre-
death arrangements until much later in the progression of their disease,
when they may not be capable of fully enjoying the money. Because it is
generally too difficult to determine the life expectancy of a chronically ill
person, it is unlikely that VSPs will viaticate or insurance companies will
accelerate the policies of such individuals. As a result, most people with
chronic illnesses should not expect to enjoy the benefits of IPAA.
Ultimately, those with heart disease, cancer, or other non-AIDS
related terminal illnesses might benefit most from HPAA. Since their life
expectancy is reasonably determinable, and no cure or adequate treatment
is in sight, VSPs and insurance companies should be more likely to offer
pre-death disbursements to these individuals. Given the advances in the
treatment of HIV/AJDS and the uncertainty of predicting death of the
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chronically ill, sufferers should investigate other means of financial
support before viaticating or accelerating a life insurance policy.
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